A Clinico-pathological Analysis of Women with Epithelial Ovarian Cancer in 20–40 Years Age Group

  • Tsering Wangdi
  • Shilpa Patel
  • Ruchi Arora
  • Ava Desai
  • Meeta H. Mankad
Original Article
  • 33 Downloads

Abstract

Purpose

The aim of this study was to analyse the clinico-pathological characteristics of epithelial ovarian cancer in young women between 20 and 40 years age group treated at Gujarat Cancer Research Institute (GCRI), Ahmadabad.

Method

Data of patients with malignant ovarian tumour in the age group of 20–40 years treated at GCRI between 2010 and 2012 were collected retrospectively. Relevant clinico-pathological data of epithelial ovarian cancer such as infertility, tumour stage, histology and grade were analysed. Surgical outcomes of patients who had primary surgery at GCRI and elsewhere were also compared. Outcomes of patient who underwent fertility-sparing surgery were also analysed.

Result

Seventy-two per cent of all the ovarian malignancy was epithelial ovarian cancers. Sixty-five per cent of the patients had advanced-stage disease. However, grade 1 and 2 disease was more common than grade 3. Fifty-eight per cent of the patients who were operated elsewhere had incomplete surgery. Overall two-year disease-free survival was 69%. Four patients who had fertility-sparing surgery were free of disease on follow-up.

Conclusions

Advanced-stage EOC was more common in this study group in contrast to other studies. Fertility-sparing surgery appears to be safe and should be considered in young patients with early-stage disease seeking future pregnancy. A greater role of gynaecologic oncologist in the management of patients with ovarian cancers is imperative for better surgical outcome and improved survival.

Keywords

Epithelial ovarian cancer Young age Fertility 

Notes

Compliance with Ethical Standards

Conflict of interest

The authors declare that they have no conflict of interest.

References

  1. 1.
  2. 2.
    Murthy NS, Shalini S, Suman G, Pruthvish S, Mathew A. Changing trends in incidence of ovarian cancer—the Indian scenario. Asian Pac J Cancer Prev. 2009;10:1025–30.PubMedGoogle Scholar
  3. 3.
    Duska LR, Chang YC, Flynn CE, Chen AH, Goodman A, Fuller AF, et al. Epithelial ovarian carcinoma in the reproductive age group. Cancer. 1999;85:2623–9.CrossRefPubMedGoogle Scholar
  4. 4.
    Chan JK, Urban R, Cheung MK, Osann K, Husain A, Teng NN, et al. Ovarian cancer in younger vs older women: a population-based analysis. Br J Cancer. 2006;95(10):1314–20.CrossRefPubMedPubMedCentralGoogle Scholar
  5. 5.
    Schilder JM, Thompson AM, DePriest PD, Ueland FR, Cibull ML, Kryscio RJ, et al. Outcome of reproductive age women with stage IA or IC invasive epithelial ovarian cancer treated with fertility-sparing therapy. Gynecol Oncol. 2002;87:1–7.CrossRefPubMedGoogle Scholar
  6. 6.
    Plaxe SC, Braly PS, Freddo JL, McClay E, Kirmani S, Howell SB. Profiles of women age 30–39 and age less than 30 with epithelial ovarian cancer. Obstet Gynecol. 1993;81(5):651–4.PubMedGoogle Scholar
  7. 7.
    Heffner LJ. Advanced maternal age—how old is too old? N Engl J Med. 2004;351:1927–9.CrossRefPubMedGoogle Scholar
  8. 8.
    Massi D, Susini T, Savino L, Boddi V, Amunni G, Colafranceschi M. Epithelial ovarian tumors in the reproductive age group: age is not an independent prognostic factor. Cancer. 1996;77:1131–6.CrossRefPubMedGoogle Scholar
  9. 9.
    Chan JK, Serrano-Olvera A, Duenas-Gonzalez A, Gallardo-Rincon D, Candelaria M, De la Garza-Salazar J. Prognostic, predictive and therapeutic implications of HER2 in invasive epithelial ovarian cancer. Cancer Treat Rev. 2006;32:180–90.CrossRefGoogle Scholar
  10. 10.
    Bacalbasa Nicolae, Balescu Irina, Dima Simona, Herlea Vlad, David Leonard, Brasoveanuetal Vladislav. Initial incomplete surgery modifies prognosis in advanced ovarian cancer regardless of subsequent management. Anticancer Res. 2015;35:2315–20.PubMedGoogle Scholar
  11. 11.
    Trimbos JB, Schueler JA, van Lent M, Hermans J, Fleuren GJ. Reasons for incomplete surgical staging in early ovarian carcinoma. Gynecol Oncol. 1990;37(3):374–7.CrossRefPubMedGoogle Scholar
  12. 12.
    Thigpen T, Brady MF, Omura GA, Creasman WT, McGuire WP, Hoskins WJ, et al. Age as a prognostic factor in ovarian carcinoma. The Gynecologic Oncology Group experience. Cancer. 1993;71(2):606–14.PubMedGoogle Scholar
  13. 13.
    Satoh T, Hatae M, Watanabe Y, Yaegashi N, Ishiko O, Kodama S, et al. Outcomes of fertility-sparing surgery for stage I epithelial ovarian cancer: a proposal for patient selection. J Clin Oncol. 2010;28(10):1727–32.CrossRefPubMedGoogle Scholar
  14. 14.
    Morice P, Wicart-Poque F, Rey A, El-Hassan J, Pautier P, Lhommé C, et al. Results of conservative treatment in epithelial ovarian carcinoma. Cancer. 2001;92:2412–8.CrossRefPubMedGoogle Scholar

Copyright information

© Association of Gynecologic Oncologists of India 2017

Authors and Affiliations

  • Tsering Wangdi
    • 1
    • 2
  • Shilpa Patel
    • 1
    • 2
  • Ruchi Arora
    • 1
    • 2
  • Ava Desai
    • 1
    • 2
  • Meeta H. Mankad
    • 1
    • 2
  1. 1.Department of Gynaecologic OncologyGujarat Cancer and Research InstituteAhmadabadIndia
  2. 2.B.J.Medical CollegeAhmadabadIndia

Personalised recommendations